Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Summary for Mega-Scandal

Mega-Scandal: Improper Drug Marketing
Description: This list shows cases in which drug companies paid penalties of $25 million or more in cases in which they were accused of promoting products for uses not authorized by government regulators.
Penalty Total since 2000: $20,653,020,587
Number of Penalty Records: 66
Note: The totals here are adjusted to account for the fact that each current parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Pfizer$3,413,800,0009
GSK plc$3,168,833,1484
Johnson & Johnson$2,653,000,0006
AbbVie$2,489,000,0005
Merck$1,788,000,0006
Eli Lilly$1,538,100,0005
AstraZeneca$1,053,400,0005
Takeda Pharmaceutical$931,500,0002
Bristol-Myers Squibb$795,000,0002
Merck KGaA (EMD)$704,000,0002

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentCurrent Parent IndustryPrimary Offense TypeYearAgencyPenalty Amount sort icon
GlaxoSmithKline LLCGSK plcpharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$3,000,000,000
Pfizer Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2009FDA$2,300,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2013FDA$2,200,000,000
Abbott Laboratories Inc.AbbViepharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Merck, Sharp & DohmeMerckpharmaceuticalsoff-label or unapproved promotion of medical products2011FDA$950,000,000
TAP Pharmaceutical Products Inc.Takeda PharmaceuticalpharmaceuticalsFalse Claims Act and related2001DOJ_CIVIL$875,000,000
Serono, S.A.Merck KGaA (EMD)pharmaceuticalsoff-label or unapproved promotion of medical products2005FDA$704,000,000
Allergan Inc.AbbViepharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$600,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $541,000,000
AstraZeneca LPAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$520,000,000
Bristol-Myers Squibb CompanyBristol-Myers Squibbpharmaceuticalsoff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Wyeth Pharmaceuticals Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2013FDA$490,900,000
GlaxoSmithKlineGSK plcpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391
Schering-Plough CorporationMerckpharmaceuticalsoff-label or unapproved promotion of medical products2006USAO$435,000,000
Warner-LambertPfizerpharmaceuticalsoff-label or unapproved promotion of medical products2004FDA$430,000,000
Cephalon IncTeva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2008FDA$425,000,000
Novartis Pharmaceuticals CorporationNovartispharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$422,500,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsFalse Claims Act and related2003DOJ_CIVIL$354,900,000
Schering-Plough CorporationMerckpharmaceuticalskickbacks and bribery2004DOJ_CIVIL$345,000,000
Abbott LaboratoriesAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Celgene Corp.Bristol-Myers SquibbpharmaceuticalsFalse Claims Act and related2017USAO$280,000,000
Serono Inc.Merck KGaA (EMD)pharmaceuticalsoff-label or unapproved promotion of medical products2005MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $262,000,000
AmerisourceBergen Specialty GroupCencora Inc.wholesalersdrug or medical equipment safety violation2017USAO$260,000,000
Wyeth Pharmaceuticals, Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000
AstraZeneca Pharmaceuticals LPAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Elan Corporation PLCPerrigopharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$203,000,000
Merck Sharp & Dohme Corp.Merckpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $201,975,000
Endo Health Solutions Inc.Endo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2014FDA$192,700,000
Aventis Pharmaceuticals Inc.SanofipharmaceuticalsFalse Claims Act and related2007DOJ_CIVIL$190,000,000
Warner-LambertPfizerpharmaceuticalsoff-label or unapproved promotion of medical products2004MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG$181,000,000
Endo Health SolutionEndo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000
Forest Pharmaceuticals Inc.AbbViepharmaceuticalsoff-label or unapproved promotion of medical products2011FDA$164,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2012TX-AG$158,000,000
Warner Chilcott PLCAbbViepharmaceuticalsoff-label or unapproved promotion of medical products2015FDA$125,000,000
Cephalon Inc.Teva Pharmaceutical Industriespharmaceuticalsoff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $116,000,000
AstraZenecaAstraZenecapharmaceuticalsFalse Claims Act and related2018TX-AG$110,000,000
GlaxoSmithKline, LLCGSK plcpharmaceuticalskickbacks and bribery2014MULTI-AG$105,000,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$95,000,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Schering-Plough CorporationMerckpharmaceuticalsoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonpharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$81,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartispharmaceuticalsoff-label or unapproved promotion of medical products2010FDA$72,500,000
Amgen Inc.Amgenpharmaceuticalsoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
AstraZeneca PharmaceuticalsAstraZenecapharmaceuticalsoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
GlaxoSmithKlineGSK plcpharmaceuticalsdrug or medical equipment safety violation2006private lawsuit-state$63,833,148
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Pfizer Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2008MULTI-AG$60,000,000
Merck & Co.Merckpharmaceuticalsconsumer protection violation2008MULTI-AG$58,000,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticalpharmaceuticalsoff-label or unapproved promotion of medical products2014FDA$56,500,000
Pfizer Inc.Pfizerpharmaceuticalsdrug or medical equipment safety violation2012FDA$55,000,000
Par Pharmaceutical Companies Inc.Endo Internationalpharmaceuticalsoff-label or unapproved promotion of medical products2013FDA$45,000,000
Elan Corp.Perrigopharmaceuticalsoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Pfizer Inc.Pfizerpharmaceuticalsoff-label or unapproved promotion of medical products2012MULTI-AG$42,900,000
CareFusion Corp.Becton Dickinsonmedical equipment and suppliesFalse Claims Act and related2014FDA$40,100,000
CareFusionBecton Dickinsonmedical equipment and suppliesoff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,100,000
Eli Lilly and CompanyEli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2005FDA$36,000,000
PfizerPfizerpharmaceuticalsoff-label or unapproved promotion of medical products2014MULTI-AG$35,000,000
Novartis Pharmaceuticals CorporationNovartispharmaceuticalsFalse Claims Act and related2016private lawsuit-federal$35,000,000
UCB Inc.UCBpharmaceuticalsoff-label or unapproved promotion of medical products2011FDA$34,000,000
Johnson & JohnsonJohnson & Johnsonpharmaceuticalsdrug or medical equipment safety violation2017MULTI-AG$33,000,000
Genzyme CorporationSanofipharmaceuticalsdrug or medical equipment safety violation2015FDA$32,587,439
Healthpoint Ltd. off-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $28,000,000
Eli Lilly and Co.Eli Lillypharmaceuticalsoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.